Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data

Journal of Pain

Volumn 16, Issue 12, 2015, Pages 1221-1232

  Andreae, Michael H ^a   Carter, George M ^b   Shaparin, Naum ^a   Suslov, Kathryn ^c   Ellis, Ronald J ^d   Ware, Mark A ^e   Abrams, Donald I ^f   Prasad, Hannah ^g   Wilsey, Barth ^g   Indyk, Debbie ^c   Johnson, Matthew ^h   Sacks, Henry S ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Foundation for Integrative AIDS Research   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Bayesian analysis; Cannabis; chronic pain; human immunodeficiency virus; meta analysis; meta analysis of individual patient data; neuropathy; painful; polyneuropathy

Indexed keywords

GELATIN; MEDICAL CANNABIS; PLACEBO; TETRAHYDROCANNABINOL; CANNABIS;

ANXIETY DISORDER; ARTICLE; BAYES THEOREM; BURNING SENSATION; CHRONIC PAIN; CLINICAL FEATURE; DISORIENTATION; DIZZINESS; DRUG WITHDRAWAL; DRY EYE; HEADACHE; HUMAN; MEMORY DISORDER; META ANALYSIS; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PARESTHESIA; PATIENT CODING; PERSONAL EXPERIENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ADULT; AGED; DRUG EFFECTS; FEMALE; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PAIN; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADULT; AGED; BAYES THEOREM; CANNABIS; CHRONIC PAIN; FEMALE; HUMANS; MALE; MEDICAL MARIJUANA; MIDDLE AGED; PAIN; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84949255591     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2015.07.009     Document Type: Article

References (90)

1. D.I. Abrams Medical marijuana: tribulations and trials J Psychoactive Drugs 30 1998 163 169
2. D.I. Abrams, C.A. Jay, S.B. Shade, H. Vizoso, H. Reda, S. Press, M.E. Kelly, M.C. Rowbotham, and K.L. Petersen Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial Neurology 68 2007 515 521
3. M.H. Andreae, and D.A. Andreae Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis Br J Anaesth 111 2013 711 720
4. M.H. Andreae, G. Carter, M. Johnson, and H. Sacks Bayesian methods improve evidence synthesis for complementary and alternative medicine: cannabis for painful HIV-related distal sensory polyneuropathy (HIV-DSPN) Reg Anesth Pain Med 36 2011 E178
5. Andreae MH, Sacks H, Indyk D, Carter G, Johnson M: Cannabis for HIV related chronic neuropathy. Available at: http://www.crd.york.ac.uk/PROSPERO/display-record.asp?ID=CRD42011001182. Accessed October 1, 2015
6. D. Ashby Bayesian statistics in medicine: a 25 year review Stat Med 25 2006 3589 3631
7. D. Ashby, and A.F. Smith Evidence-based medicine as Bayesian decision-making Stat Med 19 2000 3291 3305
8. J.C. Ashton, and E.D. Milligan Cannabinoids for the treatment of neuropathic pain: clinical evidence Curr Opin Investig Drugs 9 2008 65 75
9. N. Attal, G. Cruccu, R. Baron, M. Haanpaa, P. Hansson, T.S. Jensen, and T. Nurmikko EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Eur J Neurol 17 2010 1113 e1188
10. J.L. Azorlosa, S.J. Heishman, M.L. Stitzer, and J.M. Mahaffey Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs J Pharmacol Exp Ther 261 1992 114 122
11. P.A. Barber, S. Roberts, D.A. Spriggs, and N.E. Anderson Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana: what cardiologists need to know Am J Cardiol 113 2014 1086
12. R. Baron, A. Binder, and G. Wasner Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment Lancet Neurol 9 2010 807 819
13. S. Beard, A. Hunn, and J. Wight Treatments for spasticity and pain in multiple sclerosis: a systematic review Health Technol Assess 7 2003 iii ix-x, 41-111
14. N. Best, D. Ashby, F. Dunstan, D. Foreman, and N.A. McIntosh Bayesian approach to complex clinical diagnoses: a case-study in child abuse J R Stat Soc Ser A Stat Soc 176 2013 53 96
15. F. Birse, S. Derry, and R.A. Moore Phenytoin for neuropathic pain and fibromyalgia in adults Cochrane Database Syst Rev 2012 CD009485
16. J.M. Bostwick Blurred boundaries: the therapeutics and politics of medical marijuana Mayo Clin Proc 87 2012 172 186
17. J.M. Bostwick, G.M. Reisfield, and R.L. DuPont Clinical decisions. Medicinal use of marijuana N Engl J Med 368 2013 866 868
18. J.L. Bottorff, L.J. Bissell, L.G. Balneaves, J.L. Oliffe, N.R. Capler, and J. Buxton Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study Harm Reduct J 10 2013 2
19. F.A. Campbell, M.R. Tramer, D. Carroll, D.J. Reynolds, R.A. Moore, and H.J. McQuay Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review BMJ 323 2001 13 16
20. J.B. Carlin Meta-analysis for 2 x 2 tables: a Bayesian approach Stat Med 11 1992 141 158
21. L.E. Chaparro, P.J. Wiffen, R.A. Moore, and I. Gilron Combination pharmacotherapy for the treatment of neuropathic pain in adults Cochrane Database Syst Rev 7 2012 CD008943
22. H.W. Cohen P values: use and misuse in medical literature Am J Hypertens 24 2011 18 23
23. B. Colombo, P.O. Annovazzi, and G. Comi Medications for neuropathic pain: current trends Neurol Sci 27 2006 S183 S189
24. J.E. Cornell, C.D. Mulrow, R. Localio, C.B. Stack, A.R. Meibohm, E. Guallar, and S.N. Goodman Random-effects meta-analysis of inconsistent effects: a time for change Ann Intern Med 160 2014 267 270
25. R. Corrigan, S. Derry, P.J. Wiffen, and R.A. Moore Clonazepam for neuropathic pain and fibromyalgia in adults Cochrane Database Syst Rev 2012 CD009486
26. R.L. DuPont, and J.A. Lieberman Young brains on drugs Science 344 2014 557
27. R.H. Dworkin, A.B. O'Connor, M. Backonja, J.T. Farrar, N.B. Finnerup, T.S. Jensen, E.A. Kalso, J.D. Loeser, C. Miaskowski, T.J. Nurmikko, R.K. Portenoy, A.S. Rice, B.R. Stacey, R.D. Treede, D.C. Turk, and M.S. Wallace Pharmacologic management of neuropathic pain: evidence-based recommendations Pain 132 2007 237 251
28. R.H. Dworkin, D.C. Turk, M.P. McDermott, S. Peirce-Sandner, L.B. Burke, P. Cowan, J.T. Farrar, S. Hertz, S.N. Raja, B.A. Rappaport, C. Rauschkolb, and C. Sampaio Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations Pain 146 2009 238 244
29. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
30. R.J. Ellis, D. Rosario, D.B. Clifford, J.C. McArthur, D. Simpson, T. Alexander, B.B. Gelman, F. Vaida, A. Collier, C.M. Marra, B. Ances, J.H. Atkinson, R.H. Dworkin, S. Morgello, and I. Grant Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study Arch Neurol 67 2010 552 558
31. R.J. Ellis, W. Toperoff, F. Vaida, G. van den Brande, J. Gonzales, B. Gouaux, H. Bentley, and J.H. Atkinson Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial Neuropsychopharmacology 34 2009 672 680
32. J.T. Farrar, A.B. Troxel, C. Stott, P. Duncombe, and M.P. Jensen Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial Clin Ther 30 2008 974 985
33. N.B. Finnerup, S.H. Sindrup, and T.S. Jensen The evidence for pharmacological treatment of neuropathic pain Pain 150 2010 573 581
34. A. Gelman Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) Bayesian analysis 1 2006 515 534
35. A. Gelman, J.B. Carlin, H.S. Stern, and D.B. Rubin Bayesian Data Analysis, Vol. 2 2014 Chapman & Hall/CRC London
36. S.N. Goodman Introduction to Bayesian methods I: measuring the strength of evidence Clin Trials 2 2005 282 290 discussion 301-304, 364-378
37. D.E. Greydanus, E.K. Hawver, M.M. Greydanus, and J. Merrick Marijuana: current concepts Front Public Health 1 2013 42
38. D. Gunnell, J. Saperia, and D. Ashby Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review BMJ 330 2005 385
39. G.H. Guyatt, A.D. Oxman, R. Kunz, G.E. Vist, Y. Falck-Ytter, and H.J. Schunemann What is "quality of evidence" and why is it important to clinicians? BMJ 336 2008 995 998
40. M. Hashibe, K. Straif, D.P. Tashkin, H. Morgenstern, S. Greenland, and Z.F. Zhang Epidemiologic review of marijuana use and cancer risk Alcohol 35 2005 265 275
41. M.J. Hayes, and M.S. Brown Legalization of medical marijuana and incidence of opioid mortality JAMA Intern Med 174 2014 1673 1674
42. C. Hewitt, S. Hahn, D.J. Torgerson, J. Watson, and J.M. Bland Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals BMJ 330 2005 1057 1058
43. J.P. Higgins, S. Green Cochrane Collaboration Cochrane Handbook for Systematic Reviews of Interventions 2008 Wiley-Blackwell Chichester
44. Higgins JP Green S: Cochrane Handbook for Systematic Reviews of Interventions 5.1.0. 2011 Available at: www.cochrane-handbook.org
45. K.P. Hill Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review JAMA 313 2015 2474 2483
46. M. Iskedjian, B. Bereza, A. Gordon, C. Piwko, and T.R. Einarson Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain Curr Med Res Opin 23 2007 17 24
47. M. Joshi, A. Joshi, and T. Bartter Marijuana and lung diseases Curr Opin Pulm Med 20 2014 173 179
48. L. Kish Representation, randomization, and realism Statistical Design for Research 2004 Wiley-Interscience Hoboken, N.J xxii 267
49. I. Kissin Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J Pain Res 6 2013 513 529
50. B.S. Koppel, J.C. Brust, T. Fife, J. Bronstein, S. Youssof, G. Gronseth, and D. Gloss Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology Neurology 82 2014 1556 1563
51. J.K. Kruschke Bayesian estimation supersedes the t test J Exp Psychol Gen 142 2013 573 603
52. J.M. Leger Diagnosis of chronic neuropathy J Neurol 246 1999 156 161
53. D. Lunn, A. Thomas, N. Best, and D. Spiegelhalter WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility Stat Comput 10 2000 325 337
54. E.E. Lutge, A. Gray, and N. Siegfried The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database Syst Rev 2013 CD005175
55. M.E. Lynch, and F. Campbell Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials Br J Clin Pharmacol 72 2011 735 744
56. E. Martin-Sanchez, T.A. Furukawa, J. Taylor, and J.L. Martin Systematic review and meta-analysis of cannabis treatment for chronic pain Pain Med 10 2009 1353 1368
57. I.J. McGilveray Pharmacokinetics of cannabinoids Pain Res Manag 10 Suppl A 2005 15A 22A
58. A.E. McGlothlin, and R.J. Lewis Minimal clinically important difference: defining what really matters to patients JAMA 312 2014 1342 1343
59. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 2010 336 341
60. R.A. Moore, S. Derry, and P.J. Wiffen Challenges in design and interpretation of chronic pain trials Br J Anaesth 111 2013 38 45
61. R.A. Moore, O.A. Moore, S. Derry, P.M. Peloso, A.R. Gammaitoni, and H. Wang Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice Ann Rheum Dis 69 2010 374 379
62. R.A. Moore, P.J. Wiffen, S. Derry, T. Toelle, and A.S. Rice Gabapentin for chronic neuropathic pain and fibromyalgia in adults Cochrane Database Syst Rev 2014 Issue 4. Art. No.: CD007938
63. M. Namaka, C. Leong, A. Grossberndt, M. Klowak, D. Turcotte, F. Esfahani, A. Gomori, and H. Intrater A treatment algorithm for neuropathic pain: an update Consult Pharm 24 2009 885 902
64. A.B. O'Connor, and R.H. Dworkin Treatment of neuropathic pain: an overview of recent guidelines Am J Med 122 2009 S22 S32
65. S. Okie Medical marijuana and the Supreme Court N Engl J Med 353 2005 648 651
66. T.V. Pereira, and J.P. Ioannidis Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects J Clin Epidemiol 64 2011 1060 1069
67. T.J. Phillips, C.L. Cherry, S. Cox, S.J. Marshall, and A.S. Rice Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials PLoS One 5 2010 e14433
68. U.W. Preuss, A.B. Watzke, J. Zimmermann, J.W. Wong, and C.O. Schmidt Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients Drug Alcohol Depend 106 2010 133 141
69. J. Ramaekers, G. Kauert, and E. Theunissen Up in smoke: comparability of THC dosing across performance studies Neuropsychopharmacology 31 2006 2800
70. D.H. Rintala, S.A. Holmes, D. Courtade, R.N. Fiess, L.V. Tastard, and P.G. Loubser Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury Arch Phys Med Rehabil 88 2007 1547 1560
71. M.C. Simmonds, J.P. Higgins, L.A. Stewart, J.F. Tierney, M.J. Clarke, and S.G. Thompson Meta-analysis of individual patient data from randomized trials: a review of methods used in practice Clin Trials 2 2005 209 217
72. S.M. Snapinn, and Q. Jiang Responder analyses and the assessment of a clinically relevant treatment effect Trials 8 2007 31
73. F. Song, A. Clark, M.O. Bachmann, and J. Maas Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons BMC Med Res Methodol 12 2012 138
74. D.J. Spiegelhalter, K.R. Abrams, and J.P. Myles Bayesian approaches to clinical trials and health care evaluation 2004 Wiley Chichester
75. G.B. Stewart, D.G. Altman, L.M. Askie, L. Duley, M.C. Simmonds, and L.A. Stewart Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice PLoS One 7 2012 e46042
76. S.R. Sznitman, and Y. Zolotov Cannabis for therapeutic purposes and public health and safety: a systematic and critical review Int J Drug Policy 26 2014 20 29
77. N.D. Volkow, R.D. Baler, W.M. Compton, and S.R. Weiss Adverse health effects of marijuana use N Engl J Med 370 2014 2219 2227
78. E.J. Wagenmakers, M. Lee, T. Lodewyckx, and G. Iverson Bayesian versus frequentist inference H. Hoijtink, I. Klugkist, P. Boelen, Bayesian Evaluation of Informative Hypotheses. Statistics for Social and Behavioral Sciences 2008 Springer New York 181 207
79. J.M. Wallace Update on pharmacotherapy guidelines for treatment of neuropathic pain Curr Pain Headache Rep 11 2007 208 214
80. M.A. Ware, S. Rueda, J. Singer, and D. Kilby Cannabis use by persons living with HIV/AIDS: patterns and prevalence of use J Cannabis Therapeutics 3 2003 3 15
81. M.A. Ware, T. Wang, S. Shapiro, A. Robinson, T. Ducruet, T. Huynh, A. Gamsa, G.J. Bennett, and J.P. Collet Smoked cannabis for chronic neuropathic pain: a randomized controlled trial CMAJ 182 2010 E694 701
82. P.J. Wiffen, S. Derry, R.A. Moore, D. Aldington, P. Cole, A.S. Rice, M.P. Lunn, K. Hamunen, M. Haanpaa, and E.A. Kalso Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews Cochrane Database Syst Rev 2013 CD010567
83. S.T. Wilkinson, and D.C. D'Souza Problems with the medicalization of marijuana JAMA 311 2014 2377 2378
84. B. Wilsey, T. Marcotte, R. Deutsch, B. Gouaux, S. Sakai, and H. Donaghe Low-dose vaporized cannabis significantly improves neuropathic pain J Pain 14 2013 136 148
85. B. Wilsey, T. Marcotte, A. Tsodikov, J. Millman, H. Bentley, B. Gouaux, and S. Fishman A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain J Pain 9 2008 506 521
86. C.J. Woolf Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy Life Sci 74 2004 2605 2610
87. C.J. Woolf, and R.J. Mannion Neuropathic pain: aetiology, symptoms, mechanisms, and management Lancet 353 1999 1959 1964
88. E. Woolridge, S. Barton, J. Samuel, J. Osorio, A. Dougherty, and A. Holdcroft Cannabis use in HIV for pain and other medical symptoms J Pain Symptom Manag 29 2005 358 367
89. S. Wright Cannabinoid-based medicines for neurological disorders - clinical evidence Mol Neurobiol 36 2007 129 136
90. S.L. Zeger, K.Y. Liang, and P.S. Albert Models for longitudinal data: a generalized estimating equation approach Biometrics 44 1988 1049 1060